clinical trials, disease & medicine
Diseases From Ticks and Mosquitoes Have Tripled
Diseases From Ticks and Mosquitoes Have Tripled
Kerry Grens | May 1, 2018
Warmer weather is thought to be behind the rise in vector-borne illnesses in recent years.
Researchers Succeed in Keeping Disembodied Pig Brains Alive
Researchers Succeed in Keeping Disembodied Pig Brains Alive
Catherine Offord | May 1, 2018
The organs showed neural activity for up to 36 hours, adding fuel to discussions about the ethics of future neuroscientific research.
Bullets and Ballots
Bullets and Ballots
Bob Grant | May 1, 2018
Researching the rare, but all-too-common, disease of gun violence in America will take a concerted political effort.
Colorblindness Study Reveals Unexpected Way to Make Blood Vessels
Colorblindness Study Reveals Unexpected Way to Make Blood Vessels
Ashley Yeager | May 1, 2018
Researchers stumbled across the connection while searching for ways to reduce vision problems in people with achromatopsia.
Birth Defects Linked to Increased Risk of Childhood Cancer
Birth Defects Linked to Increased Risk of Childhood Cancer
Jim Daley | Apr 15, 2018
Certain non-chromosomal defects are strongly associated with specific childhood cancers.
New Ovarian Cancer Vaccine Shows Promise
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Vision Restored: The Latest Technologies to Improve Sight
Vision Restored: The Latest Technologies to Improve Sight
Anna Azvolinsky | Apr 10, 2018
Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.  
Shoddy Preclinical Data Used in Clinical Trial Proposals
Shoddy Preclinical Data Used in Clinical Trial Proposals
Kerry Grens | Apr 5, 2018
Applications for Phase 1 and 2 human studies in Germany frequently lack sufficient information about an intervention’s efficacy in animal experiments, according to a new study.  
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Recipients of Experimental Herpes Vaccine File Lawsuit
Recipients of Experimental Herpes Vaccine File Lawsuit
Catherine Offord | Mar 15, 2018
The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.